[1] Hu SX, Wang W, Wang Y, Litvinova M, Luo KW, Ren LS, et al. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat Commun 2021;12(1):1533. http://dx.doi.org/10.1038/s41467-021-21710-6CrossRef
[2] Office of Changde Municipal People’s Government. An asymptomatic case was reported in Changde city, Hunan province. https://www.changde.gov.cn/cdzx/cdyw/content_850758. [2022-7-26].https://www.changde.gov.cn/cdzx/cdyw/content_850758
[3] Kang M, Xin HL, Yuan J, Ali ST, Liang ZM, Zhang JY, et al. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021. Euro Surveill 2022;27(10):2100815. http://dx.doi.org/10.2807/1560-7917.ES.2022.27.10.2100815CrossRef
[4] Ogata T, Tanaka H, Irie F, Hirayama A, Takahashi Y. Shorter incubation period among unvaccinated delta variant coronavirus disease 2019 patients in Japan. Int J Environ Res Public Health 2022;19(3):1127. http://dx.doi.org/10.3390/IJERPH19031127CrossRef
[5] Del Águila-Mejía J, Wallmann R, Calvo-Montes J, Rodríguez-Lozano J, Valle-Madrazo T, Aginagalde-Llorente A. Secondary attack rate, transmission and incubation periods, and serial interval of SARS-CoV-2 omicron variant, spain. Emerg Infect Dis 2022;28(6):1224 − 8. http://dx.doi.org/10.3201/eid2806.220158CrossRef
[6] Manica M, Litvinova M, De Bellis A, Guzzetta G, Mancuso P, Vicentini M, et al. Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data. Epidemiol Infect 2022. https://doi.org/10.1017/S0950268822001947.https://doi.org/10.1017/S0950268822001947
[7] Hart WS, Miller E, Andrews NJ, Waight P, Maini PK, Funk S, et al. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. Lancet Infect Dis 2022;22(5):603 − 10. http://dx.doi.org/10.1016/S1473-3099(22)00001-9CrossRef
[8] Park SW, Sun KY, Champredon D, Li M, Bolker BM, Earn DJD, et al. Forward-looking serial intervals correctly link epidemic growth to reproduction numbers. Proc Natl Acad Sci USA 2021;118(2):e2011548118. http://dx.doi.org/10.1073/pnas.2011548118CrossRef
[9] Riley S, Wang HW, Eales O, Haw D, Walters CE, Ainslie KEC, et al. REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant. medRxiv 2021. http://medrxiv.org/content/early/2021/06/21/2021.06.17.21259103.abstract.http://medrxiv.org/content/early/2021/06/21/2021.06.17.21259103.abstract
[10] Kang M, Yi Y, Li Y, Sun LM, Deng AP, Hu T, et al. Effectiveness of inactivated COVID-19 vaccines against illness caused by the B. 1.617.2 (Delta) variant during an outbreak in Guangdong, China: a cohort study. Ann Intern Med 2022;175(4):533 − 40. http://dx.doi.org/10.7326/M21-3509CrossRef
[11] Chen XH, Yan XM, Sun KY, Zheng N, Sun RJ, Zhou JX, et al. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022. Emerg Microbes Infect 2022;11(1):2800-7. http://dx.doi.org/10.1080/22221751.2022.2128435.http://dx.doi.org/10.1080/22221751.2022.2128435
[12] Chen ZY, Deng XW, Fang LQ, Sun KY, Wu YP, Che TL, et al. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study. Lancet Reg Health West Pacific 2022;29:100592. http://dx.doi.org/10.1016/j.lanwpc.2022.100592CrossRef
[13] Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, Møller CH, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis 2022;22(7):967 − 76. http://dx.doi.org/10.1016/S1473-3099(22)00154-2CrossRef